Structure Based Drug Discovery
X-ray and cryo-EM structures of inhibitor-bound cytochrome bc₁ complexes for structure-based drug discovery
... Structure-based drug-design (SBDD) programmes are reliant upon high-resolution structures of the target protein being solved (Renaud et ...cryo-EM structure of inhibitor-bound human p97 ATPase ...
11
Structure based drug discovery for designing leads for the non toxic metabolic targets in multi drug resistant Mycobacterium tuberculosis
... 4) Rv0321 (dcd) The gene is involved in the intercon- version of dCTP and dUTP and did not have a reported GSK inhibitor. Therefore, OSDDChem database was screened against the target to identify the top 100 com- pounds ...
16
Discovery and validation of potential drug targets based on the phylogenetic evolution of GPCRs
... important drug targets for the pharmaceutical ...dimensional structure of a protein is of utmost impor- tance for drug discovery, as it serves as the basis for the identification of novel ...
44
Investigating ethnopharmacology based natural product leads for antimalarial drug discovery
... Studies using X-ray crystallography, nuclear magnetic resonance technology (NMR) and spectroscopic techniques have shown haemozoin and β-haematin to be identical in structure and solubility profile (Slater et al., ...
219
The Success of Natural Products in Drug Discovery
... or drug candidates have been ...space based on their physico- chemical characteristics, is often used to describe the difference between the combinatorial chemistry libraries and natural ...compounds), ...
15
Molecular dynamics simulations and drug discovery
... a drug target that had not seemed amenable to structure-based drug ...viral drug raltegravir, the first US Food and Drug Admin- is tration-approved HIV integrase ...
9
Structure-based drug design: aiming for a perfect fit.
... Although fragments typically bind with a low potency, they form efficient interactions with the protein target and thus provide attractive starting points for inhibitor design. Nowadays, a plethora of different methods ...
7
Structure-Based Discovery of Inhibitors Against MurE in Methicillin-Resistant Staphylococcus Aureus
... pharmacophore based on the structure of MurE Sa was generated and used to screen a total of 7,144 approved and experimental drugs from DrugBank ...a drug known to act on structurally related MurA ...
8
Novel Approach for Drug Discovery
... are based on a lattice of pairwise distances between taxa (or any sort of items): The goal is to build a tree with branch lengths so that the distances between the leaves in that tree are as close as conceivable ...
19
Breakthroughs in Computational Approaches for Drug Discovery
... in Discovery Studio (Accelrys, ...and structure-based approaches by generating energetically optimized SB pharmacophores that can be used to rapidly screen billions of ...
5
Biological Motif Discovery Algorithm based on Mining Tree Structure
... As there are a big growing interest on regulatory element that can lead to understand some virus function, detect new drug, classify spices, or to get many other helpful new knowledge of biology. The researchers ...
6
The discovery of potent ribosomal S6 kinase inhibitors by high- throughput screening and structure-guided drug design
... present. Although the S6K1 construct is considerably shorter than the PKA and PKA-S6K1 chimera sequences, the overall tertiary SK61 structure is very similar to the PKA-S6K1 chimera (rmsd 1.33 Å for 247 equivalent ...
15
CURRENT TRENDS IN DRUG DISCOVERY: TARGET IDENTIFICATION TO CLINICAL DEVELOPMENT OF THE DRUG
... hit structure, with modifications chosen by employing structure-activity analysis (SAR) as well as structure-based design if structural information about the target is available 18 ...
5
Computational Approaches in Drug Discovery: An Overview
... Drug discovery and development process involves a series of events that include target identification and validation, lead identification and optimization, pre-clinical pharmacology and ...Computer-aided ...
7
The development of sialidase inhibitors using structure based drug design
... quinic acid were used in the discovery of oseltamivir (von Itzstein, 2007). Three key strategies were employed to develop an orally administered NA inhibitor: 1) positioning of the double bond, 2) replacement of ...
244
Development and application of ligand-based and structure-based computational drug discovery tools based on frequent subgraph mining of chemical structures
... previous studies in this as well as several other laboratories demonstrated that no correlation exists between leave-one-out (LOO) cross-validated R 2 (q 2 ) for the training set and the correlation coefficient R 2 ...
148
PROTEIN INTERACTION NETWORK AND DRUG DISCOVERY
... dimensional structure of protein molecules are widely investigated, based on small world network approaches, with an emphasis on different combinations of descriptors affecting the structure which ...
9
Interferon, viruses and drug discovery
... One of the most commonly used approaches to target elucidation is affinity-chromatography (Titov and Liu, 2012, McFedries et al., 2013). Cell lysates are incubated with affinity-tagged compound followed by standard ...
221
The Drug Discovery Development for Treatment of Tuberculosis
... important drug target for some of the most efficient anti-mycobacterial drug molecules ...(AGP), based mycolic acids are accoladed by glycolipids such as ...
18
Pharmacogenomics: Applications in Drug Discovery and Pharmacotherapy
... in drug metabolism and response both interms of therapeutic action and adverse ...in drug response. (Ensom, M. H. et al; 2001). Drug–drug interactions (DDIs) have shown serious effects like ...
14